HLA-A and cancer: For example, a bispecific antibody that binds to the TCR CD3 and a phosphopeptide presented in HLA‐A*02:01 was shown to target cytolytic T cells to cancer cells in vitro, resulting in T‐cell–induced apoptosis.106